OTC records inspection legislation would have little impact on agency policy -- FDAers.
This article was originally published in The Tan Sheet
Executive Summary
OTC DRUG RECORDS INSPECTION INCREASED FREQUENCY UNLIKELY if authorized under pending FDA reform legislation, FDA Central Region Assistant Director Joseph Phillips told the Nonprescription Drug Manufacturers Association Manufacturing Controls Seminar in Philadelphia Oct. 9-10. "I wouldn't expect to see us storming out there to demand what we haven't done in the past," Phillips commented.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning